{"changes":[],"country":"US","description":"Exai Bio is developing an RNA-based liquid-biopsy platform that uses proprietary oncRNA biomarkers plus AI to detect early-stage cancer from a blood draw. Customers are clinicians and care pathways looking for non-invasive multi-cancer screening or recurrence monitoring. The team's pitch is finding cancer signals in what looks like noise to other platforms.","domain":"exai.bio","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":"exai","githubStars":null,"industry":"unknown","investors":[],"lat":37.444329,"lng":-122.159847,"location":"palo alto, ca, usa","name":"EXAI BIO INC","rounds":[{"amountQuarantined":false,"amountUsd":1300000,"currency":"USD","date":"2024-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"exai-bio","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"exai.bio","retrievedAt":"2026-05-05","status":"self-reported","url":"https://exai.bio"},{"fact":"description","publisher":"exai.bio","retrievedAt":"2026-05-05","status":"self-reported","url":"https://exai.bio"}],"stage":null,"techStack":["Cloudflare","Google Analytics","Google Font API","Google Hosted Libraries","Google Tag Manager","jsDelivr","WordPress","PHP","MySQL","jquery 3.5.1"],"totalRaisedUsd":1300000,"updatedAt":"2026-05-05"}